register

News & Trends - MedTech & Diagnostics

Competitive grants to turn MedTech discoveries into clinical reality

Health Industry Hub | October 21, 2019 |

Cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

This round will direct funding to projects in three focus areas:

  • Digitally enabled medical devices in mobile health, health information technology, wearable devices, telehealth and telemedicine, and digitally enabled personalised medicine.
  • Implantable digitally enabled medical devices addressing unmet needs in any therapeutic area.
  • General medical devices in the areas of regenerative medicine, women’s health, cardiovascular, orthopaedics, neuroscience, general surgery and oncology.

The funding will be available through a competitive process. The three focus areas will support development of biomedical and medical technologies in the priority areas, to the proof of concept stage and towards to commercial development.

New medical treatments and technology supported by BMT Horizons funding will result in better health outcomes, and quality of life for Australians and people around the world. In some cases, they will be life changing or even lifesaving.

Looking for talent?
Post a job to reach Pharma, MedTech and Biotech industry professionals.
High reach. Engaged industry audience.
Cost effective.
Contact us

They will also fuel growth in Australia’s biomedical and medical technology sector. As projects mature and reach commercialisation, they will create jobs and generate domestic and export income.

Further details are available at:
https://www.health.gov.au/initiatives-and-programs/biomedtech-horizons

You may also like New report highlights value of accessing cataract treatment through the prostheses list


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.